EAU 2021 personalized medicine for mHSPC, treatment for metastatic hormone-sensitive prostate cancer, PROfound trial, personalized medicine in advanced prostate cancer, de novo mHSPC patients, VISION trial.
Aquagenic urticaria, a rare dermatological condition characterised by urticarial eruptions following water contact, poses significant diagnostic and therapeutic challenges. This condition, although uncommon, necessitates heightened…
The ESMO Sarcoma and Rare Cancers Congress 2025 programme is now online!
Pelotonia announced today an annual fundraising total of $26,200,095 in 2024, bringing all-time funds raised to $309,861,962 for innovative cancer research at
To learn more about the program’s eligibility and how to apply please review all of the information on our APPLY page before starting an application…
Leukemia – Managing the unmanageable: evidence-driven approaches to real-world patient prototypes of TP53-mutant myelodysplastic neoplasms and acute myeloid leukemia
Blood Cancer Journal – Venetoclax combined with three-day multi-frequency decitabine (DEC3-VEN) in elder or intensive chemotherapy ineligible patients with newly diagnosed acute myeloid leukemia
EAU 2021 personalized medicine for mHSPC, treatment for metastatic hormone-sensitive prostate cancer, PROfound trial, personalized medicine in advanced prostate cancer, de novo mHSPC patients, VISION…
Les listes PS-VOORUIT, PTB et ECOLO-GROEN s’unissent au service de tous les Forestois.es à travers un accord de majorité solidaire, ambitieux et responsable. Cet accord…
Donald Trump has called on Christopher Rufo.
